{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"67.1","upperLimit":"81.8","value":"74.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"137"}],"units":"Participants"}],"description":"Number of participants who achieved partial response (PR) or better according to IMWG Uniform Response Criteria for Multiple Myeloma as assessed by an independent response committee (IRC).","dispersionType":"95% Confidence Interval","groups":[{"description":"BB2121","id":"OG000","title":"BB2121"}],"paramType":"NUMBER","populationDescription":"All Treated Participants","reportingStatus":"POSTED","timeFrame":"From first dose to 24 Months","title":"Overall Response Rate","type":"PRIMARY","unitOfMeasure":"Percentage of Participants"}